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Cardiac disease exacerbation is associated with short-term 
exposure to vehicular emissions. Diesel exhaust (DE) might 
impair cardiac performance in part through perturbing effer-
ent sympathetic and parasympathetic autonomic nervous system 
(ANS) input to the heart. We hypothesized that acute changes in 
ANS balance mediate decreased cardiac performance upon DE 
inhalation. Young adult heart failure–prone rats were implanted 
with radiotelemeters to measure heart rate (HR), HR variability 
(HRV), blood pressure (BP), core body temperature, and pre-
ejection period (PEP, a contractility index). Animals pretreated 
with sympathetic antagonist (atenolol), parasympathetic antag-
onist (atropine), or saline were exposed to DE (500  µg/m3 fine 
particulate matter, 4 h) or filtered air and then treadmill exer-
cise challenged. At 1 day postexposure, separate rats were cath-
eterized for left ventricular pressure (LVP), contractility, and 
lusitropy and assessed for autonomic influence using the sympa-
thoagonist dobutamine and surgical vagotomy. During DE expo-
sure, atenolol inhibited increases in HR, BP, and contractility, but 
not body temperature, suggesting a role for sympathetic domi-
nance. During treadmill recovery at 4 h post-DE exposure, HR 
and HRV indicated parasympathetic dominance in saline- and 
atenolol-pretreated groups that atropine inhibited. Conversely, 
at treadmill recovery 21 h post-DE exposure, HRV and PEP 
indicated sympathetic dominance and subsequently diminished 
contractility that only atenolol inhibited. LVP at 1  day postex-
posure indicated that DE impaired contractility and lusitropy 
while abolishing parasympathetic-regulated cardiac responses to 
dobutamine. This is the first evidence that air pollutant inhalation 
both causes time-dependent oscillations between sympathetic and 
parasympathetic dominance and decreases cardiac performance 
via aberrant sympathetic dominance.
Key Words: air pollution; autonomic; cardiac function; cardio-
vascular; diesel exhaust; electrocardiography; heart failure; heart 
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Near-road air pollution exposure is associated with adverse 
clinical events, especially in those with preexisting cardiac dis-
ease (Bell et al., 2009; Brook, 2008; Mann et al., 2002; Pope 
et  al., 2008). Multiple pollutants are implicated, including 
fine and ultrafine particulate matter (PM
2.5
 and UFP, diameters 
< 2.5 µm and < 0.1 µm, respectively), nitrogen dioxide (NO
2
), 
carbon monoxide (CO), and sulfur dioxide (SO
2
). Diesel 
exhaust (DE) is a major urban source of these pollutants, 
volatile organics, and carbonyls and may thus contribute to 
pollutant-induced adverse cardiac events. Leading candidate 
mechanisms of DE’s cardiac toxicity include changes in myo-
cardial perfusion, ion channel and exchanger function, and 
autonomic nervous system (ANS) regulation that can com-
promise the viability, electrical stability, and pump function 
(performance) of the heart.
Several studies indicate that DE inhalation can impair perfu-
sion and electrical stability within the myocardium and alter 
autonomic modulation (Anselme et al., 2007; Campen et al., 
2005; Carll et al., 2012, 2013; Hazari et al., 2011, 2012; Lamb 
et al., 2012; Mills et al., 2007). We recently showed that short-
term DE inhalation increases arrhythmia susceptibility in 
hypertensive rats through sympathetic dominance 1 day after 
exposure (Hazari et  al., 2011). The belief that DE may also 
impair the heart’s ability to contract and relax has been sup-
ported only by studies involving crude exposures and lacking 
insight on potential mechanisms (Gordon et al., 2012; Huang 
et al., 2010; Minami et al., 1999; Yan et al., 2008). Conversely, 
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we observed in aged heart failure–prone rats that DE inhalation 
caused parasympathetic dominance and, 1 h after exposure, 
increased cardiac output (Carll et al., 2013). As such, research 
has yet to demonstrate that DE inhalation impairs cardiac per-
formance or that autonomic imbalance mediates such effects. 
Therefore, we examined the effects of acute DE inhalation on 
cardiac performance and autonomic imbalance in heart fail-
ure–prone rats, including the day after exposure, which we 
have found corresponds with sympathetic-mediated arrhythmia 
susceptibility. To more directly determine whether the ANS 
mediates impairments in cardiac performance, we incorpo-
rated pharmacologic, surgical, and physiological interventions 
in heart failure–prone rats, which have particular cardiac sus-
ceptibility to DE. We hypothesized that DE exposure would 
adversely affect cardiac performance by inducing autonomic 
imbalance.
Epidemiologists have used the electrocardiogram (ECG) to 
link air pollution exposure to changes in autonomic balance 
in part by identifying changes in heart rate variability (HRV). 
Because exertion increases cardiac workload and provokes auto-
nomic compensatory reflexes (sympathetic activation during 
exercise and parasympathetic activation thereafter), ECG meas-
urements during exercise stress tests are useful for unmasking 
aberrant autonomic regulation of the heart (Goldberger et al., 
2006) and cardiovascular risk. Increases in heart rate (HR) or 
HRV during recovery from treadmill exercise are predictive 
of cardiovascular mortality (Dewey et  al., 2007; Watanabe 
et al., 2001). Additionally, exercise tests in patients with hyper-
trophic cardiomyopathy can provoke a transient cardiac pump 
dysfunction that is predictive of adverse outcomes (Pelliccia 
et  al., 2007). As we have shown, sympathetic agonists (e.g., 
dobutamine) may also be used to mimic exercise and unmask 
latent effects of DE exposure, including impaired HR recovery, 
increased arrhythmia, and ECG indications of ischemia (Hazari 
et al., 2012). To determine the influence of DE on cardiac per-
formance and assess the role of the ANS in these effects, we 
measured responses in blood pressure (BP), HR, ECG, pre-
ejection period (PEP), and HRV to exposure and subsequent 
treadmill exercise in heart failure–prone rats pretreated with 





-muscarinic) modulation of the heart. 
At 1 day after exposure, we also assessed cardiac performance 
in a subset of rats by left ventricular pressure (LVP) before and 
during two dobutamine infusions separated by surgical vagot-
omy to test for parasympathetic mediation of effects. Here we 
provide the first evidence that DE exposure may impair cardiac 
mechanical function through sympathetic dominance.
MATERiALS AND METHoDS
Animals. Lean male spontaneously hypertensive heart failure rats (SHHF 
MccCrl-Leprcp) were obtained from Charles River Laboratories. These rats 
acquire cardiac hypertrophy by 2 months and dilated cardiomyopathy and overt 
heart failure at 18 months (Carll et al., 2012). Intermediately, neurohormonal 
and sympathetic activation compensates for a loss of contractile function and 
promotes myocardial remodeling.
DE exposure and generation. Animals were exposed to either whole 
DE (target 500 µg PM
2.5
/m3) or filtered air (Air) under conditions previously 
described (Table 1) (Carll et al., 2012, 2013). DE exposures were at ultrafine 
PM and NO
2
 concentrations comparable to observations in United States and 
European traffic tunnels and roadways (Anselme et  al., 2007; Svartengren 
et  al., 2000; Zhu et  al., 2007). DE originated from a single-cylinder 0.320 
l displacement Yanmar L70 V diesel generator operated at 3600 rpm on low 
sulfur diesel fuel (16 ppm) at a 3 kW load and was diluted with high efficiency 
particulate air (HEPA)-filtered room air and delivered to exposure chambers 
as previously described (Carll et al., 2012). Control (“Air”) animals received 
HEPA-filtered room air in a second exposure chamber.
Study 1—Treadmill Exercise Stress Test and Pharmacologic Autonomic 
Inhibition
Radiotelemeter implantation. Rats were implanted with radiotelemeters 
transmitting ECG, aortic BP, and core body temperature (n  = 24, 8 weeks 
old, telemeter model TL11M2-C50-PXT, Data Sciences International) at 
Charles River as described previously (Carll et al., 2010) and shipped after 
a 10-day recovery to our AAALAC International–approved animal facility at 
the EPA. Additional SHHF rats (n = 15, 11–12 weeks old) were implanted in-
house with radiotelemeters measuring ECG, HR, and core body temperature 
(model TA11CTA-F40) (Lamb et al., 2012). The rats were housed individu-
ally in Plexiglas cages with pine-shave bedding in an animal holding room 
(22 ± 1°C, 50 ± 5% relative humidity, 12-h light:dark cycle, 0600:1800 h) and 
provided standard Purina rat chow (5001; Brentwood, MO) and water ad libi-
tum. All studies conformed to the guidelines of the U.S. EPA Institutional 
Animal Care and Use Committee (IACUC). After ≥ 10 days of surgical recov-
ery, rats were transferred to a satellite facility and maintained as previously 
detailed (Carll et al., 2013).
Drugs and exercise challenge. Animals were assigned to one of six treat-
ment groups (Air-Saline, Air-Atropine, Air-Atenolol, DE-Saline, DE-Atropine, 
and DE-Atenolol) maintaining equivalent mean body weights and ages 
between groups. Rats were trained for treadmill challenge on 2 days before 
baseline treadmill challenges with telemetry. Each challenge involved an initial 
4-min run (Run A), a 20-min resting period, and a 5-min run (Run B). See 
Supplementary figure S1.
The rats were placed in exposure chambers for a 2-h acclimation and 






 (µg/m3) 1.9 (0.3) 502 (2.8)
Volume median diameter of PM (nm) 184 89
O
2
 (%) 20.9 (0.0) 20.3 (0.1)
CO (ppm) < 0.5 33.1 (2.3)
NO (ppm) < 0.5 23.4 (1.8)
NO
2
 (ppm) < 0.5 3.8 (0.22)
SO
2
 (ppm) < 0.5 < 0.5
Temperature (°F) 73.9 (1.3) 71.7 (0.8)
Humidity (%) 43.8 (2.6) 56.1 (1.2)
Note. Means (SEM in parentheses) from continuous (concentrations of O
2
, 




 mass concentration), or six (DE PM
2.5
 num-
ber) measurements per exposure day. Volume diameter was calculated from 
number-based mobility diameters and assumed spherical particles. Air indi-
cates filtered air; DE, diesel exhaust; PM
2.5
, fine particulate matter.
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approximately 3 and 20 h after end of sham, animals received treadmill chal-
lenges. Inhalation exposures began 3 days after sham. At 1 h before exposure, 
atropine and atenolol were each dissolved into saline, twice sonicated and vor-
texed for 2 min, and maintained at 38°C. Rats (12–15 weeks old) were weighed 
and injected ip with saline vehicle (0.9% NaCl, Sigma), atropine or atenolol 
(5 mg/kg each, Sigma) at 2.5 ml/kg, placed in exposure chambers immediately 
thereafter, and allowed 30 min to equilibrate before whole-body exposure for 
4 h to either whole DE or filtered air, followed by a 1 h washout period in which 
only filtered air was circulated through exposure chambers. Animals were 
returned to home cages and treadmill challenged again at 4 and 21 h after ces-
sation of DE exposures (3 and 20 h post washout).
Radiotelemetry and ECG. Radiotelemetry was used to continuously 
monitor ECG, BP, core body temperature, and activity in conscious unre-
strained rats from 3 days before exposure until euthanasia 24 h postexposure. 
Arterial BP (mean, systolic, diastolic, and pulse), HR, and aortic PEP were 
automatically calculated by software (DataART 3.01; DSI) from pressure 
and ECG waveforms sampled at 1000 Hz for 2 of every 10 min within home 
cages, 2 of every 12 min within exposure chambers, and continuously during 
treadmill challenges. The PEP (sometimes termed QA interval) provides an 
inverse index of contractility measured by the delay between onset of left 
ventricular (LV) depolarization and ejection, indicated by initializations of 
the R wave and an increase in aortic pressure, respectively (Cambridge and 
Whiting, 1986). We previously found that drug-induced cardiomyopathy 
increased PEP in proportion to decreases in aortic dP/dt
max
, another index of 
contractility not examined in this study (Carll et al., 2010). From treadmill 
HR data, we also calculated HR recovery time (time required from peak exer-
cise for HR to return to within 25 BPM of 3-min prerun mean), HR increase 
(change at peak exercise from 3-min prerun mean), and HR decrease (change 
from peak exercise at 3-min recovery).
ECG waveforms were analyzed during exposure and treadmill for HRV, 
morphology, and arrhythmia with computer software (ECGauto 2.8.1.26; 
EMKA Technologies, Falls Church, VA) as previously detailed (Carll et al., 
2012). HRV analysis generated HR and time-domain measures, including 
mean time between adjacent QRS-complex peaks (RR interval), standard 
deviation of the RR interval (SDNN), square root of the mean of squared dif-
ferences of adjacent RR intervals (RMSSD), and percent of adjacent normal 
RR intervals differing by ≥ 15 ms (pNN15). SDNN represents overall HRV, 
whereas pNN15 and RMSSD represent parasympathetic influence over HR 
(Rowan et al., 2007). HRV analysis also provided frequency-domain parame-
ters, including low frequency (LF: 0.200–0.750 Hz, representing a combination 
of sympathetic and parasympathetic tone) and high frequency (HF: 0.75–3.50 
Hz, indicating parasympathetic tone), and the ratio of these two (LF/HF, indi-
cating sympathovagal balance) analyzed with a Hanning window for segment 
lengths of 512 samples with 50% overlapping (Rowan et al., 2007). Arrhythmia 
identification and exclusion from HRV and ECG morphology analyses were 
performed blind to treatment and according to previously described criteria 
(Carll et al., 2012, 2013).
We limited midexposure HRV analysis to 1–2 h after initialization of DE 
because this period corresponded with the most significant alterations in HR 
and BP in the DE-Saline group relative to the Air-Saline group. Because signif-
icant effects of DE on HRV and HR during treadmill occurred only at recovery 
from Run B at 4 h postexposure and recovery from Run A at 21 h postexposure, 
we only report these values. Because significant changes in PEP and systolic 
BP were limited to recovery from Run B for 21 h postexposure, we only report 
these parameters during this period at 4 and 21 h postexposure.
Tissue collection and analysis. At 24 h after the 4-h exposure, rats were 
deeply anesthetized with sodium pentobarbital/phenytoin solution, ip. Tissue 
samples of blood, lung lavage fluid, heart, and lungs were collected, processed, 
and analyzed as previously described (Carll et al., 2012). To examine for indi-
cations of cardiopulmonary inflammation, injury, oxidative stress, and risk, 
assays of multiple biochemical markers were performed identical to our previ-
ous description (Carll et al., 2013).
Study 2—LV Pressure, Dobutamine Stress Test, and Vagotomy
SHHF rats (n = 10, 13.5 weeks old) were exposed by whole-body inhala-
tion to DE or Air and, at 20–24 h after exposure, anesthetized with urethane 
(1.5 mg/kg ip, Sigma) and then prepared for LVP measurement by right 
carotid arterial catheterization with a 2 French transducer (SPR-320, Millar 
Instruments). The LV probe was connected via a Pressure Control Unit (Model 
2000, Millar Instruments) to a receiver (Powerlab 4/30, ADInstruments) and a 
computer acquiring data at 1000 Hz. The left jugular vein was cannulated for 
cardiac stress test by sympathomimetic infusion (dobutamine). The transducer 
was advanced into the left ventricle for a 4-min baseline, and freshly diluted 
dobutamine hydrochloride (dissolved in 0.9% NaCl saline at 640 µg/ml) was 
infused for 2 min at a dose of 320  µg/kg/min iv (infusion A). For regimen, 
see Figure 6. Rats were observed for 12 min after infusion cessation, which 
pilot studies revealed as adequate time for recovery to resting HR and dP/dt
max
. 
Animals then received bilateral vagotomy by suture occlusion followed by a 
stabilization period (3 min), another 2-min infusion at the same dose (infusion 
B), a postinfusion observation period (2.5 min), and subsequent euthanasia by 
exsanguination. Software (LabChart Pro 7.3.2, ADInstruments) generated HR, 
Fig. 1. Study 1 regimen. Effects of DE inhalation on cardiovascular physiology during exposure and after treadmill exercise. ECG and BP were measured 
by radiotelemetry. Animals were pretreated with an autonomic inhibitor or saline control 30 min before whole-body exposure to clean air or DE at a target PM 
concentration of 500 µg/m3 and challenged 4 and 21 h later by repeat treadmill exercise (Run A and Run B) separated by a 20 min resting period. Sham exposure 
to filtered air for both groups occurred 3 days before actual exposure.
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pressure at end diastole and end systole (EDP and ESP), and the maximum and 




, respectively) per beat, indica-
tive of contractility and relaxation rate (lusitropy), respectively. HR peaked 
within the first 110 s of infusion at equal raw values for both groups and began 
decelerating in control rats thereafter. Because the differences in HR decelera-
tion (difference from peak) and dP/dt
min
 (difference from baseline) were most 
pronounced at the last 10 s of dobutamine infusion, we analyzed and report 
values from this time point.
Statistics. Analyses were performed using Prism 4.03 (GraphPad 
Software, San Diego, CA). Repeated measures two-way ANOVA with 
Bonferroni post hoc test was performed on LV pressure data. To control for 
effects of containment in exposure chambers and enable comparisons between 
groups in effects of treatment, treadmill data at 4 and 21 h after sham exposure 
(“Baseline”) were subtracted from treadmill data at 4 and 21 h after actual 
exposure and compared between all groups at corresponding treadmill periods 
(“Prerun,” “Run,” or “Recovery”) by two-way ANOVA with Bonferroni post 
hoc test and (to control for autonomic effects of pharmacologic inhibitors) by 
repeat measures two-way ANOVA between the DE- and Air-exposed groups 
administered the same drug. Additionally, ANOVA with Tukey test was used 
on nonphysiological endpoints. For all analyses, p  <  0.05 was considered 
statistically significant.
RESuLTS
Study 1. Effects During Exposure and Treadmill Recovery
Exposure. Relative to the corresponding Air groups, DE 
significantly increased HR in saline- and atropine-treated 
rats at hour 1 of exposure (+  50 and 78 BPM, respectively) 
while increasing mean arterial pressure (MAP, + 25  mmHg) 
and shortening PEP (−3.3 ms) only in atropine-treated rats at 
this time (all p < 0.05, data not shown). At hour 2 of exposure, 
DE continued to increase HR for both saline- (+ 85 BPM) and 
atropine-treated groups (+ 51 BPM) from their corresponding 
Air groups, while DE increased MAP (+ 33 mmHg) and short-
ened PEP (−2.8 ms) only for the saline-treated group (Fig. 2; 
all p  <  0.05), indicating an increase in contractility. DE sig-
nificantly increased core temperature at hour 1 for the saline-, 
atropine-, and atenolol-pretreated groups (+ 0.9°C, + 1.3°C, + 
1.2°C, respectively, data not shown) and hour 2 (+  2.1°C, + 
1.8°C, and + 0.8°C, Fig. 2) relative to Air controls, respectively 
Fig. 2. Box and whisker plots of physiological changes from sham exposure. DE increased HR, BP, cardiac contractility (shortened PEP), and body tempera-
ture during exposure hour 2 relative to Air. Atenolol blocked all effects except on temperature. Dash indicates median, box ends mark 75th and 25th percentile, 
respectively, and whiskers indicate maximum and minimum values. Stars indicate differences between Air and DE groups, and diamonds indicate differences 
from Saline-pretreated group of corresponding inhalation exposure (p < 0.05). HR and core temperature: N = 5–9 per group. MAP and PEP: N = 4 per group.
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(all p  <  0.05). Mid-exposure HRV analysis was restricted to 
hour 2 of exposure, during which DE did not affect HRV rela-
tive to Air regardless of pretreatment. During exposure hour 
3 and also hour 5 (washout) in exposure chambers when only 
clean filtered air was delivered, DE exposure had no significant 
effect on the aforementioned parameters regardless of pretreat-
ment. Sympathetic inhibition with atenolol prevented DE from 
affecting HR, MAP, and PEP at all time points of exposure. 
The hypertensive effects of DE appeared to reverse to hypo-
tensive effects by hour 4 of exposure for rats pretreated with 
saline (−13 mmHg; p > 0.05) and significantly reversed for rats 
pretreated with atropine (−25 mmHg; p < 0.05) relative to their 
corresponding Air group.
With Air exposure, drug pretreatments also had noteworthy 
effects relative to saline. Atropine significantly increased HR 
and MAP at exposure hour 2 (Fig. 2) as well as over the entire 
exposure relative to Air-saline (48 ± 3 vs. −11 ± 3 BPM and 
18 ± 6 vs. −3 ± 2  mmHg) driven by increases at hours 1–3 in 
HR (+ 53‒74 BPM) and hours 2‒3 in MAP (+ 20‒22 mmHg; 
all p < 0.05). At hour 2 of exposure, Atropine also significantly 
decreased RMSSD relative to saline regardless of DE or Air 
exposure (Supplementary fig. S2), likely obscuring effects of 
DE on HRV. Atenolol did not significantly affect these meas-
ures during any hour of exposure.
Treadmill stress test. Prior to treatment, treadmill exercise 
increased HR to approximately 500 BPM in all groups. At 4 h 
postexposure, HR and HRV responses differed significantly 
between the DE and Air groups only during the recovery from 
the second consecutive run (Run B) of the exercise challenge 
(Fig.  3). Specifically, DE exposure in saline-pretreated rats 
increased SDNN and RMSSD by 4.4 and 1.2 ms, respectively, 
relative to the Air-Saline group (both p < 0.05). Meanwhile, DE 
at 4 h postexposure in atenolol-pretreated rats decreased HR 
(Fig.  3, −67 BPM vs. Air-Atenolol) but did not significantly 
affect HRV. DE had no similar effects on the atropine group at 
4 h postexposure (p > 0.05).
At 21 h postexposure (Fig. 4), the DE-Saline group exceeded 
its air-exposed counterpart in change in HR and LF/HF by 32 
BPM and 0.99 units, respectively, while it fell significantly 
below the Air-Saline group in RMSSD (−1.0 ms; all p < 0.05), 
collectively suggesting sympathetic dominance. Importantly, 
Fig. 3. HR and HRV during recovery from the second of two treadmill runs at 4 h postexposure. DE increased SDNN and RMSSD in saline-pretreated rats 
and decreased HR in atenolol-pretreated rats. Atropine inhibited these effects of DE. N = 5–9 per group. Stars indicate differences between Air and DE groups, 
and diamonds indicate differences from Saline-pretreated group of corresponding inhalation exposure (p < 0.05). 
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all of these effects occurred at recovery from the initial treadmill 
run (Run A). Conversely, DE prolonged PEP relative to Air at 
recovery from the second consecutive run (Run B) in saline- 
and atropine-treated rats, suggesting decreased contractility 
(Fig. 5; + 2.2 and 2.1 ms, respectively, p < 0.05). Concomitantly, 
DE decreased systolic BP in atropine-pretreated rats relative 
to their air-exposed counterparts and trended toward a similar 
effect in saline-pretreated rats (p = 0.12). In contrast, atenolol 
pretreatment inhibited the aforementioned changes in HRV, 
BP, and PEP seen 24 h after DE exposure.
There were no significant effects of DE or Air exposure on 
arrhythmia frequency, HR increase, HR decrease, HR recovery 
time, or ECG morphology during treadmill exercise challenges 
(data not shown). There were no clear effects of DE or auto-
nomic inhibitors on biochemical measures of oxidative stress, 
inflammation, or cardiopulmonary injury (data not shown).
Study 2. Effects on LV Pressure and Autonomic Modulation
Predobutamine infusion. At 1  day after inhalation expo-
sure, DE decreased contractility (dP/dt
max
: Air, 6489 ± 399 vs. 
DE, 5425 ± 259 mmHg/s; p = 0.056), slowed LV relaxation (dP/
dt
min
: Air, −8294 ± 409 vs. DE, −6145 ± 460 mmHg/s; p < 0.05), 
and increased LV filling pressure (EDP: Air, 0.42 ± 1.6 vs. DE, 
4.4 ± 0.9 mmHg; p < 0.05, Fig. 6B). DE did not affect HR, arte-
rial pressure, or ESP before infusion (all p > 0.05).
Infusion A. Dobutamine increased HR by approximately 
150 BPM for both groups during the first 110 s of infusion 
relative to preinfusion, with no significant raw differences 
between peak HRs (Air vs. DE: 464.9 ± 6.4 vs. 480.0 ± 6.3 BPM; 





no difference between the peak values of DE and Air groups; 
however, during the final 10 s of infusion, the Air group had a 
greater increase in dP/dt
min
 from preinfusion and a greater deceler-
ation from peak HR than the DE group (Figs. 6C and D) (p < 0.05 
for all). At the “Recovery” period 12 min after infusion stopped, 
both groups decreased in HR and dP/dt
max
 to values comparable 
to preinfusion, whereas only the Air group maintained an elevated 
dP/dt
min
 relative to its preinfusion value (Supplementary fig. S3, 
p < 0.05), which was now equivalent to the DE group.
Fig. 4. HR and HRV during recovery from the initial of two treadmill runs at 21 h postexposure. DE increased HR and LF/HF (a measure of sympathetic/
parasympathetic influence), and it decreased RMSSD. Treatment with either atropine or atenolol inhibited all of these effects. N = 5–9 per group. Stars indicate 
differences between Air and DE groups, and diamonds indicate differences from Saline-pretreated group of corresponding inhalation exposure (p < 0.05).
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Vagus nerve ablation and infusion B. Vagotomy increased 
HR and dP/dt
max
 for both groups relative to their own values 
at preinfusion and recovery (p  <  0.05; Supplementary fig. 
S3), indicating successful inhibition of parasympathetic input. 
In addition, vagotomy did not alter the DE group’s lusitropy, 
whereas it restored the Air group to preinfusion dP/dt
min
. 
Importantly, vagotomy significantly decreased the Air group’s 
responses to dobutamine in both dP/dt
min
 and HR decelera-
tion (Figs. 6C and D, relative to infusion A; p < 0.05), making 
them comparable to those of DE-exposed animals, which were 
unchanged from prevagotomy. There were no significant differ-
ences between groups in HR or dP/dt
max
 during or after infusion 
B nor in BP after infusion.
DiSCuSSioN
We demonstrate in hypertensive heart failure–prone rats 
that a single 4-h exposure to DE by inhalation impairs cardiac 
performance, in part, through sympathetic dominance. One day 
after exposure, DE altered intracardiac pressures consistent with 
diminished systolic and diastolic mechanical function, while 
DE also decreased cardiac contractility during exercise recovery 
and depressed vagal-mediated chronotropic and lusitropic 
reflexes to adrenergic stimulation (Table 2). Additionally, DE 
increased LV filling pressure (EDP) and impaired LV relaxation 
(dP/dt
min
). These effects might offer insight into epidemiological 
findings that short-term air pollution exposure increases heart 
failure–related hospitalizations and deaths (Bell et  al., 2009; 
Mann et  al., 2002; Pope et  al., 2008) and complement our 
observation that DE causes LV dilation in aged SHHF rats 
(Carll et al., 2013).
Our findings suggest that DE inhalation causes sympathetic 
dominance, which subsequently diminishes cardiac mechanical 
function. Importantly, only atenolol inhibited sympathetic 
cardiovascular effects during DE exposure and prevented 
decreased contractility 1 day later. Interestingly, at 1 day after 
exposure, sympathetic dominance upon recovery from the 
initial treadmill run appeared to obscure any effects of DE on 
contractility, which only emerged after a repeat treadmill run, 
when autonomic imbalance dissipated. Similarly, a repeated 
exercise in humans with hypertrophic cardiomyopathy has been 
shown to unmask latent contractility deficits that were more 
predictive of long-term health decline than systolic decrements 
during an initial exercise (Pelliccia et  al., 2007). Thus, our 
observations may bear particular clinical relevance.
The autonomic effects of DE in saline-treated rats involved 
oscillations from sympathetic dominance during exposure to 
parasympathetic dominance 4 h after exposure and back to sym-
pathetic dominance 1 day after exposure. Inhalation of concen-
trated ambient particles in dogs has been shown to similarly alter 
HRV in a bipolar manner (Godleski et al., 2000). These oscilla-
tions in autonomic imbalance offer some resolution to conflict-
ing reports of only parasympathetic or sympathetic dominance 
upon air pollutant exposure. Direct assessments of receptor and 
ion channel expression and functionality may offer more pre-
cise insight into the etiology of these effects. Nevertheless, the 
data reveal that short-term DE exposure causes time-dependent 
oscillations in autonomic balance, among which early sympa-
thetic dominance may initiate the bulk of systolic dysfunction. 
Ultimately, this study complements clinical observations (de 
Hartog et al., 2009; Pekkanen et al., 2002) by demonstrating 
that β
1
-adrenergic blockade might prevent air pollutant-induced 
cardiac dysfunction.
Notably, sympathetic dominance 1  day after exposure 
potentially compensated for impaired inotropy, as it dissipated 
upon repeat exercise concomitant with decreased contractility. 
Yet, atropine inhibited this sympathetic dominance but 
did not prevent DE from decreasing contractility after the 
Fig. 5. PEP (inverse index of contractility) and systolic BP during recovery from the second of two treadmill runs at 21 h postexposure. DE significantly decreased 
contractility (prolonged PEP) in both saline- and atropine-pretreated groups, and it also decreased systolic BP in atropine-pretreated rats. N = 4 per group. Stars indicate 
differences between Air and DE groups, and diamonds indicate differences from Saline-pretreated group of corresponding inhalation exposure (p < 0.05).
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subsequent run. Thus, this delayed sympathetic dominance 
may have resulted from mechanisms independent of contractile 
dysfunction, such as muscarinic receptor desensitization 
secondary to parasympathetic hyperactivation (Maloteaux 
and Hermans, 1994). Accordingly, atropine could have 
preempted sympathetic dominance on the day after exposure 
through parasympathetic inhibition on the day of exposure. 
Yet, the benefits of this late sympathoinhibition are unclear 
because only sympathetic dominance during DE exposure 
appeared to mediate a subsequent decrease in contractility. 
Intracardiac pressure measurements in atenolol-pretreated 
animals might provide a more clear demonstration of when 
and if DE-induced sympathetic dominance mediates decreased 
cardiac performance.
We observed several effects of DE that indicate a central 
role for sympathetic mediation and deserve comparison to our 
previous findings (Fig. 7). We have found that aged SHHF rats 
have parasympathetic dominance during whole DE exposure 
and bradyarrhythmias immediately thereafter (Carll et  al., 
2013), contrasting with the sympathetic dominance and 
steady heart rhythms that we observed in young adult SHHFs 
here and previously (Carll et  al., 2012). Bred for its genetic 
predisposition to  heart failure, this strain replicates important 
human cardiovascular risk factors and cardiac deficits, 
progressing from compensated hypertrophic cardiomyopathy 
at 2  months to dilated cardiomyopathy and decompensated 
heart failure at 18 months of age primarily as a consequence of 
hypertension (Carll et al., 2011, 2012). Heart failure progression 
might increase sensitivity to inhaled irritants or hypertension, 
thereby provoking more pronounced trigeminocardiac (Gorini 
et al., 2010), baroreceptor, or cardiac mechanoreceptor reflexes 
that increase parasympathetic tone and bradyarrhythmia 
(Carll et  al., 2013). Nevertheless, our data from young adult 
SHHF rats indicate sympathetic dominance during or shortly 
after exposure, parasympathetic dominance at about 4 h 
postexposure, and—in both Spontaneously Hypertensive and 
SHHF rats—sympathetic dominance at 1  day postexposure 
(Fig. 7).
The current study revealed unique chronotropic, hyper-
tensive, hyperthermic, and inotropic effects during DE expo-
sure. These findings may have emerged because each animal 
was normalized by its own time-matched 4-h sham exposure 
instead of the 1-h preexposure baseline we have traditionally 
used, thereby controlling for the confounding reductions in 
Fig. 6. Study 2 regimen (A). DE impaired baseline LV systolic function (decreased dP/dt
max
), diastolic relaxation (increased dP/dt
min
), and chamber filling 





, respectively), (C) change in dP/dt
min
 from preinfusion to final 10 s of infusion, and (D) change from peak HR during 
infusion to final 10 s of infusion. Stars indicate differences between Air and DE groups, and diamonds indicate differences from a group’s own values at infusion 
A (p < 0.05). N = 5 per group.
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activity that tend to occur over the course of our chamber expo-
sures (Carll et al., 2012). We saw a hyperthermic response in 
the current study that was consistent with sympathetic domi-
nance and likely persisted during exposure despite β
1
-blockade 
because thermogenesis is mediated by sympathetic stimulation 
of the β
3
-receptor. Finally, by performing treadmill challenges 
and analyzing HRV during exercise recovery, we found new 
evidence that DE caused sympathetic dominance and decreased 
contractility on the day after exposure.
Oxidative stress might underlie the observed effects, as it 
can cause sympathetic dominance with PM exposure (Rhoden 
et al., 2005) and decrease cardiac performance (Dhalla et al., 
2000). Air pollutant exposure has been repeatedly linked 
with oxidative stress (cardiac and systemic) and increased 
sympathetic influence (Brook, 2008). Alternatively, increased 
circulating NO has been observed for up to 2 h after DE inhala-
tion (Knuckles et al., 2011) and can increase HR by directly 
stimulating the sinoatrial node (Chowdhary et al., 2002) while 
possibly leaving HRV unaffected. This latter mechanism may 
explain why the typical inverse relationship between HRV and 
HR was absent during this and our prior inhalation exposures 
(when animals ranged from ambulatory to asleep). Yet, the res-
toration of this relationship while animals remained still during 
treadmill recovery suggests that HRV and HR may uncouple 
with spontaneous activity, further highlighting the importance 
of physiologic controls in HRV assessments (Hautala et  al., 
2010). Finally, although we controlled for PM
2.5
 concentra-
tions between studies, the NO
2
 and CO levels were, for reasons 
Fig. 7. Our recent investigations show that DE inhalation and cardiac dysfunction are linked to autonomic imbalance in heart failure–prone SHHF rats and 
in Spontaneously Hypertensive (SH) rats. *, before challenge DE diminished LV contractility (CTY) and lusitropy and increased LV filling pressure. Results are 
shown for exposure to whole DE only. CO, cardiac output. Circled or superscript numbers represent the following investigations: 1present studies with young adult 
SHHF rats; 2Carll et al., 2012, young adult SHHF rats; 3Hazari et al., 2011, SH rats; 4Hazari et al., 2012, SH rats; 5Carll et al., 2013, aged SHHF rats.
TABLE 2
Summary of DE Effects on Cardiovascular Physiology for Both Studies Relative to Air groups of the Corresponding Drug Treatment
Time Challenge




Exposure hour 1 — ↑HR ↑HR, BP, CTY — DE caused sympathetic  
dominance, inhibited by 
atenolol
Exposure hour 2 — ↑HR, BP, CTY ↑HR —
Exposure hour 4 — — ↓BP —
4 h post-DE After repeat run ↑SDNN, RMSSD — ↓HR DE caused parasympathetic dom-
inance, inhibited by atropine
1 day post-DE After initial run ↑HR, LF/HF, ↓RMSSD — — DE caused sympathetic  
dominance, inhibited by  
atenolol and atropine
After repeat run ↓CTY ↓CTY, BP — DE impaired LV contraction, 
inhibited by atenolol
LVP study Immediately before dobutamine  
(1 day post-DE)
↓LTY, CTY*, ↑EDP DE impaired LV contraction, 
relaxation, and chamber filling
First 2-min infusion of dobutamine 
(110–120 s)
Diminished HR deceleration and lusitropic response 
during final 10 s of dobutamine infusion
DE diminished parasympathetic 
inhibitory reflexes to 
sympathetic activation
Note. DE caused oscillations from sympathetic dominance (midexposure) to parasympathetic dominance (4 h postexposure) to sympathetic dominance (day 
after exposure) in saline-treated rats. In the LVP study, contractility (CTY), lusitropy (LTY), and end-diastolic pressure (EDP) were all altered on the day after 
exposure, indicating impaired LV contraction and relaxation. Only statistically significant effects (p < 0.05) are reported, with exception to *p = 0.056. No signifi-
cant effects were seen at exposure hour 3 or the exposure washout period (hour 5), during which filtered air was delivered to all groups.
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unclear, several-fold higher in this study than previously. 
Therefore, the discrepancies between our current and past 
findings (Carll et  al., 2012, 2013; Hazari et  al., 2012; Lamb 
et al., 2012) may stem from differences in study design, includ-
ing anesthesia, concentrations of gaseous components, animal 
susceptibility, differences in baselines (i.e., a full sham expo-
sure vs. a brief baseline), and the divergent effects of exercise 
relative to sympathomimetic challenge or spontaneous activity. 
Our studies collectively indicate that both parasympathetic and 
sympathetic dominance can occur with DE exposure in a time- 
and susceptibility-dependent manner.
The responses of DE- and air-exposed rats to dobutamine 
infusion and vagotomy indicate that DE impaired parasym-
pathetic modulation of the heart. Importantly, DE exposure 
and vagotomy each individually inhibited lusitropic and 
chronotropic responses to dobutamine, indicating that DE, at 
24 h postexposure, elicits similar effects on heart function as 
parasympathectomy. In concordance with our recent findings 
(Hazari et al., 2012), air-exposed rats had inhibitory chrono-
tropic reflexes to dobutamine that DE exposure abolished. 
Recapitulation of this effect by vagotomy in air-exposed rats 
appears to confirm that this effect was parasympathetic in ori-
gin. Thus, the responses to both dobutamine and vagotomy 
demonstrate that DE may degrade normal parasympathetic 
modulation, thereby enabling increased sympathetic influence 
and inevitably impeding cardiovascular function.
DE exposure caused autonomic imbalance that may relate 
to the triggering of pulmonary irritant receptors, including the 
transient receptor potential ankyrin 1 (TRPA1) channel, which 
activate sensory nerves (C-fibers) (Hazari et al., 2011), thereby 
causing acute autonomic cardiovascular reflexes (Widdicombe 
& Lee, 2001). We have previously shown that both (1) the 
inhibition of TRPA1 channels prior to DE exposure and (2) 
the administration of a sympathetic antagonist 1  day after 
DE exposure prevent DE-enhanced sensitivity to aconitine, a 
proarrhythmic drug (Hazari et  al., 2011). Others have found 
that a 3-day PM
2.5
 inhalation exposure in mice decreases car-
diac vagal neuron excitability and HRV, indicating that air 
pollutant exposure can compromise the parasympathetic coun-
terbalance to sympathoexcitation through induced neuroplas-
ticity (Pham et al., 2009). Similar effects have recently been 
found in SO
2
-exposed rats (Woerman and Mendelowitz, 2013). 
Importantly, although the parasympathetic branch has minimal 
effects on vascular tone relative to sympathetic input (Friberg 
et al., 1988), it suppresses sympathetic influence over the car-
diovascular system through a number of mechanisms, includ-
ing presynaptic inhibition of sympathetic neurons, inhibition 
of catecholamine release, and decreased firing rates of the 
sinoatrial and atrioventricular pacemaker nodes (Katz, 2006). 
Thus, it remains unclear whether our observations derive from 
diminished parasympathetic or enhanced sympathetic neural 
regulation of the heart. Nevertheless, decreased vagal tone 
and increased sympathetic influence over the heart have been 
found to correspond with heart failure exacerbation and predict 
arrhythmia and sudden cardiac death in humans (La Rovere 
et al., 1994; Nolan et al., 1998). Similarly, increased HR and 
HRV during exercise recovery are predictive of cardiovas-
cular mortality (Dewey et  al., 2007; Watanabe et  al., 2001). 
Therefore, regardless of the exact neural etiology, our findings 
that sympathetic dominance preceded impaired cardiac func-
tion may illuminate epidemiological observations of increased 
cardiovascular morbidity and mortality with acute air pollution 
exposure. Moreover, these observations support the growing 
hypothesis that indications of autonomic imbalance may serve 
as biomarkers of air pollutant cardiotoxicity.
CoNCLuSioN
We incorporated treadmill exercise with autonomic-inhibiting 
drugs and, separately, a sympathoagonist with parasympathetic 
ablation to reveal that air pollution caused cardiac performance 
decrements that may be partly mediated by the ANS. We found 
that a commonly prescribed inhibitor of sympathetic neural 
regulation of the heart (a β
1
-adrenergic receptor blocker) can 
prevent DE from impairing a measure of contractility. We also 
revealed that DE impaired cardiac performance concomitant 
with diminished parasympathetic modulation. Although the 
relevance of this to long-term exposures remains unclear, our 
findings offer important insight into the mechanistic basis and 
prevention of air pollution’s adverse effects on the heart.
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